Fatal drug-drug interaction between 5-fluorouracil and brivudine;Interacción farmacológica mortal entre 5-fluorouracilo y brivudina

Farmacia Hospitalaria

Volumn 37, Issue 1, 2013, Pages 72-73

  Garcia Fernandez V ^a   Garrido Arevalo M ^a   Labrada Gonzalez E ^a   Hidalgo Correas, F J ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; FLUOROURACIL;

NOTE;

ADENOCARCINOMA; ANTIMETABOLITES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BROMODEOXYURIDINE; COLONIC NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; SEPSIS;

EID: 84876247449     PISSN: 11306343     EISSN: 21718695     Source Type: Journal    
DOI: 10.7399/FH.2013.37.1.271     Document Type: Note

References (8)

1. Nervinex (brivudina). Ficha técnica. Actualizado marzo 2010; con-sultado enero 2012. Disponible en Centro de Información online de Medicamentos de la AEMPS-CIMA http://www.aemps.gob.es/cima/fichasTecnicas.do? metodo=detalleForm
2. De Clercq E. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. Biochem Pharmacol. 2004 Dec 15;68(12):2301-15.
3. España A, Redondo P. Actualización en el tratamiento del herpes zóster. Actas Dermosifiliogr. 2006 Mar;97(2):103-14.
4. Keizer HJ, De Bruijn EA, Tjaden UR. Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-de- oxyuridine. Cancer Res Clin Oncol. 1994;120(9):545-9.
5. Okuda H, Ogura K, Kato A. A Possible Mechanism of Eighteen Patient Deaths Caused by Interactions of Sorivudine, a New Antiviral Drug, with Oral 5-Fluorouracil Prodrugs. J Pharmacol Exp Ther. 1998 Nov; 287(2):791-9.
6. Baena-Cañada JM, Martínez MJ, García-Olmedo O. Interaction between capecitabine and brivudin in a patient with breast cancer. Nat Rev Clin Oncol. 2010 Jan;7(1):55-8.
7. Rätz Bravo AE, Hofer S, Krähenbühl S. Fatal drug-drug interaction of brivudine and capecitabine. Acta Oncol. 2009;48(4):631-3.
8. Burgos A y Ordovás J P. Interacciones farmacoterapéuticas clínicamente significativas en Oncología. En Oncología Farmacéutica, Jiménez Torres NV ed. Universitat de València. Valencia 2006. pp. 285-94.